Plavix News
Most Popular Plavix Story
FDA turns thumbs down on Multaq
Sanofi-Aventis says that the FDA has rejected its heart drug Multaq (dronedarone), evidently unsatisfied with the data provided to support its application. Multaq is designed to treat atrial fibrillation. Sanofi-Aventis hasn't given up on the drug, though. The company says it plans to refile for approval in the first half of 2008, after it receives a fresh batch of data from an ongoing study. Last February the FDA rejected Sanofi-Aventis' bid to market Acomplia. And analysts weren't happy …
Read more...Latest Headlines
- November 18, 2009
- November 17, 2009
- August 31, 2009
- May 13, 2008
- March 31, 2008
- February 22, 2008
- January 4, 2008
- November 28, 2007
- November 21, 2007
- November 19, 2007
- November 5, 2007
- October 25, 2007
- June 25, 2007
- June 24, 2007
- January 28, 2007
- November 6, 2006
- October 25, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
